191 related articles for article (PubMed ID: 26633608)
1. Human papillomavirus vaccination crisis in Japan.
Dornbusch HJ; Stiris T; Del Torso S; Ross-Russell R; Zavrsnik J; Wettergren B; Mercier JC; Valiulis A; Hadjipanayis A
J Paediatr Child Health; 2015 Dec; 51(12):1146-7. PubMed ID: 26633608
[TBL] [Abstract][Full Text] [Related]
2. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
3. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
[TBL] [Abstract][Full Text] [Related]
4. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers.
Gerend MA; Shepherd MA; Lustria ML
Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130
[TBL] [Abstract][Full Text] [Related]
5. HPV vaccination: a decade on.
Lancet; 2016 Jul; 388(10043):438. PubMed ID: 27507742
[No Abstract] [Full Text] [Related]
6. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
8. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
9. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
10. Who should get the HPV vaccine?
Pichichero ME
J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
[No Abstract] [Full Text] [Related]
11. Evaluation of fotonovela to increase human papillomavirus vaccine knowledge, attitudes, and intentions in a low-income Hispanic community.
Chan A; Brown B; Sepulveda E; Teran-Clayton L
BMC Res Notes; 2015 Oct; 8():615. PubMed ID: 26514184
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Vaccine - Knowledge and Attitudes among Parents of Children Aged 10-14 Years: a Cross-sectional Study, Tîrgu Mureş, Romania.
Voidăzan S; Tarcea M; Morariu SH; Grigore A; Dobreanu M
Cent Eur J Public Health; 2016 Mar; 24(1):29-38. PubMed ID: 27070967
[TBL] [Abstract][Full Text] [Related]
13. New initiatives to improve HPV vaccination rates.
Palfrey S
Hum Vaccin Immunother; 2016 Jun; 12(6):1594-8. PubMed ID: 26930138
[No Abstract] [Full Text] [Related]
14. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
17. Beyond resumption of the Japanese Government's recommendation of the HPV vaccine.
Ueda Y; Yagi A; Ikeda S; Enomoto T; Kimura T
Lancet Oncol; 2018 Dec; 19(12):1563-1564. PubMed ID: 30507414
[No Abstract] [Full Text] [Related]
18. [Vaccines against human papillomavirus (HPV); between registration and implementation].
van Rossum TG; de Melker HE; Houweling H; Voordouw AC; Meijer CJ; Helmerhorst TJ; Kretzschmar M; Berkhof J; van der Noordaa J
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):987-92. PubMed ID: 18549172
[TBL] [Abstract][Full Text] [Related]
19. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
20. Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation.
Zimet GD; Rosberger Z; Fisher WA; Perez S; Stupiansky NW
Prev Med; 2013 Nov; 57(5):414-8. PubMed ID: 23732252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
